GTCR LLC entered into a definitive agreement to acquire Surmodics, Inc. for approximately $620 million on May 28, 2024. Under the terms of the agreement, affiliates of GTCR will acquire all.
Merck to Acquire EyeBio for Up to $3B, Re-Entering Eye Drug Space genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
We are delighted to share the U.S. chapter we wrote for Chambers & Partners' 2024 Corporate M&A Guide. In our chapter below, you will find insights on the current M&A landscape.
The Company1 enters agreement with Numab Therapeutics to acquire its wholly owned subsidiary2 for the global rights to NM26, a Phase 2-ready investigational, first-in-class bispecific antibody.